Adaptimmune Therapeutics PLC (ADAPY) SEC Filings & Financial Intelligence
Adaptimmune Therapeutics PLC (ADAPY) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADAPY
CIK: 1621227
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSimon Haydn-Jones
Audit LocationReading, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| RW | 2026-04-22 | — | RW | 0001104659-26-046473 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-17 | — | SCHEDULE 13G Filing | 0001019056-26-000043 | View SEC Doc Filr Page |
| EFFECT | 2025-11-14 | — | EFFECT Filing | 9999999995-25-003290 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001011438-25-000554 | View SEC Doc Filr Page |
| 424B3 | 2025-11-13 | — | 424B3 Filing | 0001193805-25-001571 | View SEC Doc Filr Page |
| 15-12G | 2025-11-13 | — | 15-12G | 0001104659-25-110847 | View SEC Doc Filr Page |
| S-8 POS | 2025-10-28 | — | S-8 POS | 0001104659-25-103166 | View SEC Doc Filr Page |
| S-8 POS | 2025-10-28 | — | S-8 POS | 0001104659-25-103165 | View SEC Doc Filr Page |
| S-8 POS | 2025-10-28 | — | S-8 POS | 0001104659-25-103163 | View SEC Doc Filr Page |
| POS AM | 2025-10-28 | — | POS AM | 0001104659-25-103158 | View SEC Doc Filr Page |
| 25 | 2025-10-28 | — | FORM 25 | 0001104659-25-102828 | View SEC Doc Filr Page |
| 8-K | 2025-10-20 | 2025-10-15 | 8-K | 0001104659-25-100618 | View SEC Doc Filr Page |
| 3 | 2025-10-08 | 2025-09-10 | OWNERSHIP DOCUMENT | 0001104659-25-098032 | View SEC Doc Filr Page |
| 8-K | 2025-09-26 | 2025-09-22 | 8-K | 0001104659-25-093882 | View SEC Doc Filr Page |
| 8-K | 2025-09-12 | 2025-09-11 | 8-K | 0001104659-25-089558 | View SEC Doc Filr Page |
| 8-K | 2025-09-08 | 2025-09-06 | 8-K | 0001558370-25-011925 | View SEC Doc Filr Page |
| 4 | 2025-09-03 | 2025-09-02 | OWNERSHIP DOCUMENT | 0001104659-25-087085 | View SEC Doc Filr Page |
| 144 | 2025-09-02 | — | 144 Filing | 0001104659-25-086007 | View SEC Doc Filr Page |
| 4 | 2025-08-29 | 2025-08-28 | OWNERSHIP DOCUMENT | 0001104659-25-085820 | View SEC Doc Filr Page |
| 144 | 2025-08-29 | — | 144 Filing | 0001104659-25-085819 | View SEC Doc Filr Page |
| 8-K | 2025-08-29 | 2025-08-29 | 8-K | 0001558370-25-011820 | View SEC Doc Filr Page |
| 4 | 2025-08-19 | 2025-08-15 | 4 | 0000950170-25-110254 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-08-19 | — | SCHEDULE 13D/A Filing | 0001072613-25-000670 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-19 | — | SCHEDULE 13G/A Filing | 0000935836-25-000544 | View SEC Doc Filr Page |
| 8-K | 2025-08-15 | 2025-08-15 | 8-K | 0001558370-25-011616 | View SEC Doc Filr Page |